Moody's Investors Service, Standard & Poor's, and Fitch Ratings made the rating cut because of the debt Boston Scientific is taking on to finance the deal, and because of the legal liability it inherits from Guidant over faulty internal cardioverter-defibrillators. We probably won't be seeing Boston Scientific buying anything else for a while.
MDDI Online is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.